JPH0322149B2 - - Google Patents
Info
- Publication number
- JPH0322149B2 JPH0322149B2 JP23559083A JP23559083A JPH0322149B2 JP H0322149 B2 JPH0322149 B2 JP H0322149B2 JP 23559083 A JP23559083 A JP 23559083A JP 23559083 A JP23559083 A JP 23559083A JP H0322149 B2 JPH0322149 B2 JP H0322149B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- diatomaceous earth
- acid
- filamentous fungi
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 30
- 239000005909 Kieselgur Substances 0.000 claims description 21
- 241000233866 Fungi Species 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 238000012258 culturing Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 4
- 239000002609 medium Substances 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 17
- 239000000126 substance Substances 0.000 description 16
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 14
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000004366 Glucose oxidase Substances 0.000 description 8
- 108010015776 Glucose oxidase Proteins 0.000 description 8
- 108091005804 Peptidases Proteins 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 8
- 229940116332 glucose oxidase Drugs 0.000 description 8
- 235000019420 glucose oxidase Nutrition 0.000 description 8
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 8
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 8
- 229960000951 mycophenolic acid Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 7
- 102100022624 Glucoamylase Human genes 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 241000228212 Aspergillus Species 0.000 description 5
- 241000228143 Penicillium Species 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 4
- 241001619326 Cephalosporium Species 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- 241000228145 Penicillium brevicompactum Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 229940056360 penicillin g Drugs 0.000 description 4
- 229940098377 penicillium brevicompactum Drugs 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 241000228150 Penicillium chrysogenum Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229960005261 aspartic acid Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 description 2
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000589519 Comamonas Species 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 101100020289 Xenopus laevis koza gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は糸状菌の培養法に関する。
従来より、珪藻土類に属する粉体を有用物質を
生産する目的で液体培地に添加して糸状菌を培養
した例はペニシリウム・クリソゲナムに属する糸
状菌を用いたペニシリンG醗酵に於て、菌体の固
定化の目的でセライトを10%という高濃度で添加
した例(D.I.C.Wang等、昭和57年度日本発酵工
学会講演要旨集p112)が知られているのみであ
り、低濃度の珪藻土類を液体培地に添加して糸状
菌を培養した例は未だ報告されていない。
一般に糸状菌を液体培地中で好気的に培養する
と菌糸はペレツト状(球状)又はパルプ状の塊に
なつて生育し、時にはこの塊が大きく成長するた
めに目的としている有用物質の生産が著しく低下
することが糸状菌を用いた有用物質生産に於ける
欠点の一つであつた。
本発明者等は制ガ剤、有機酸、抗生物質、プロ
テアーゼ、グルコアミラーゼ、グルコースオキシ
ダーゼなどの酵素類、L−アミノ酸、色素及び酵
素阻害剤等の有用物質の生産を目的として、糸状
菌に属するそれぞれの生産菌を珪藻土を含有する
培養液中で培養した結果、菌糸の塊が微細化され
ると同時に目的とする有用物質の生産が著しく促
進されることを見出し、本発明を完成するに至つ
た。
すなわち、本発明は珪藻土類に属する粉体8%
を越えない範囲で含有する液体培地中で糸状菌を
好気的に培養することを特徴とする糸状菌の培養
法に関する。
本発明に使用される珪藻土としては、古くから
過助剤として使用されているもので、製造会社
及び粒度によつて種々の商品名がある。例えば
Johns−Manville社製品では各種セライト
「Celite501〜577」、「ハイフロスーパーセル」及
び「フイルターセル」があり、昭和化学工業(株)製
品では、各種「ラジオライト」、「ラピツドフロ
ー」及び各種「トーライト」があり、白山工業(株)
製品では各種「ゼムライト」及び「ゼムライトス
ーパー」があり、Grefco社製品では各種「デイ
カライト」(「Dicalite」)があり、そしてEagle−
Picher社製品では各種「セラトム」(「Celatom」)
がある。使用する珪藻土は一般に入手出来るその
ままの形でよく(粉体)、培地に添加する前に培
地と別にして180〜200℃で乾熱滅菌するか、又は
通常の条件で蒸気滅菌するか、又は培地と共に蒸
気滅菌してもよい。
培地中への珪藻土の添加により胞子及び菌糸
が、珪藻土の粒子に付着し、これを核にして発芽
し、菌糸が成長している様子が観察され、更に珪
藻土に付着せず、しかも塊にもならずに成長して
いる様子も観察される。かくして珪藻土添加によ
り菌糸は大きな塊にならずに生育し、培地の撹拌
効率も改善され、増殖速度及び目的とする有用物
質の生産が促進されるという結果が得られる。
本発明において生産する有用物質とは糸状菌が
生産する有用物質であり、例えばミコフエノール
酸、サイクロスポリン等の制ガン剤、グルコン
酸、クエン酸、リンゴ酸、ピルビン酸、イタコン
酸、アラボアスコルビン酸、コウジ酸、アロイソ
クエン酸等の有機酸、ペニシリン、セフアロスポ
リンC等の抗生物質、プロテアーゼ、グルコアミ
ラーゼ、グルコースオキシダーゼ等の酵素類、L
−アミノ酸、色素類及びコンパクチン、酵素阻害
剤をあげることができる。
本発明において用いる糸状菌は糸状菌であれば
特に限定することはなく、例えばミコフエノール
酸及びコンパクチンを生産するペニシリウム・ブ
レビコンパクタム、ペニシリンC生産菌であるペ
ニシリウム、クリソゲナム、グルコースオキシダ
ーゼ生産菌であるペニシリウム・パープロゲナ
ム、セフアロスポリンC生産菌であるセフアロス
ポリウム・ポリアレウラム、アミラーゼ生産菌で
あるアスペルギルス・オリゼ、リゾープス・デレ
マ、プロテアーゼ生産菌であるアスペルギルス・
サイトイ、アスペルギルスフエニシス、クエン
酸、グルコン酸生産菌であるアスペルギルス・ニ
ガー、イタコン酸生産菌であるアルペルギルス・
テレウス等をあげることができる。具体的にはミ
コフエノール酸生産菌であるペニシリウム・ブレ
ビ・コンパクタム(Penicillium brevi−
compactum)、AJ117096、(FERM P−5693、
FERM BP−55)、ペニシリン生産菌であるペニ
シリウムクリソゲナム(P.chrysogenum)
ATCC10002、AJ7343、グルコースオキシダーゼ
生産菌であるペニシリウム・パープロゲナムNo.
778(P.purprogenum)AJ17045 FERM−P1846、
セフアロスポリンC生産菌としてセフアロスポリ
ウム・ポリアレラム(Cephalosporium
polyaleurum)ATCC20359 AJ6993、プロテア
ーゼ生産菌としてはアスペルギルス・フエニシス
(Aspergillusphenicis)ATCC14332 AJ17063、
グルコアミラーゼ及びクエン酸生産菌としてアス
ペルギルス・ニガー(A.niger)ATCC9642
AJ7172等が使用される。
本発明において使用する液体培地は珪藻土を添
加する以外は糸状菌が生育する液体培地であれば
どのような培地でも使用できる。例えばミコフエ
ノール酸生産用培地としては公知の培地、W.L.
Muth et al、Antimicrob、Agents
Chemtherap.、8、321−327(1975)記載の培地
等が使用される。ペニシリン醗酵用培地としては
Lohnson等の合成培地(住木諭介“抗生物質”
上、p.177、1961)が使用される。セフアロスポ
リンC発酵用培地としては、例えばA.L.
DEMAIN、J.F.NEWKIRK、and D.
HENDLIN、J.Bacteriol.85、339(1963)記載
の培地の改変培地(第4表)が使用される。グル
コースオキシダーゼ生産用培地としては、例えば
特公昭52−109公報記載の培地が使用される(第
6表)。プロテアーゼ、グルコアミラーゼ及びク
エン酸生産用培地としては第5表、第6表に記載
の培地が使用される。
珪藻土の添加量は8%を越えない範囲であり、
好ましくは0.2〜2%である。培養温度は有用物
質を生産する糸状菌が生育できる温度であればど
のような温度でも良いが、有用物質を生産する至
適培養温度を使用することが好ましい。それぞれ
の有用物質の生産に好適の条件で回転又は通気撹
拌培養する。回転速度は200〜250rpmである。珪
藻土の添加方法としては、単独又は二種以上の組
合せがある。
本発明の方法によつて生産される各種有用物質
は各々の公知の方法で定量及び採取することがで
きる。培養液中のミコフエノール酸及びクエン酸
は高速液体クロマトグラムにより分析定量を行
い、アスパラギン酸はバイオアツセイ法でペニシ
リンGの定量はStaphyloccus aureusを用いる国
家検定法、セフアロスポリンCはComamonas
ferrigenaの生育阻止円法を用いて行つた。グル
コアミラーゼ活性の測定は糖化測定法(“実験化
学講座”24巻、p272 1961)、プロテアーゼ活性
の測定はCasein−Folin呈色A法(萩原“酵素研
究法第2巻.p.237 1956年)、グルコースオキシ
ターゼの活性の測定はワールブルグマノメーター
を用いる検圧法で行なつた。
以上説明したように本発明は珪藻土を培地中に
添加して糸状菌の生産する有用物質を蓄積採取す
る方法に関したものであり、本発明の方法は珪藻
土の添加により有用物質の生産量を著しく高める
ものであり、かつ生産物採取後の培養液からの珪
藻土の回収が焼却等の方法により容易に回収でき
る点で工業的実用価値はきわめて大きい。
実施例 1
ペニシリウムブレビコンパクタムAJ117096
(FERM P−5693、FERM BP−55)を第1表
に示す天然斜面培地に接種し、27℃にて10日間培
養後、胞子を採取し、0.1Mリン酸緩衝液(PH
6.8)に懸濁し、その一定容量を第2表に示す培
地(300ml用三角フラスコに50ml培地張込み)に
接種し(約106個胞子/ml)、27℃にて12日間
226rpmで回転培養を行つた。第3表に示した珪
藻土を添加する場合は予め180℃で加熱滅菌した
後に1%になるように培地に添加した。培養後、
培養液を水酸化ナトリウム溶液によりPH10〜10.5
に調整し20分間150rpmで回転した後、東洋紙
No.2を用いて過して透明な液を得る。この
液中のミコフエノール酸を高速液体クロマトグラ
ムにより定量し、L−アスパラギン酸はバイオア
ツセイ法により定量した。菌の生育は培地全体
(50ml)の菌体を、約10mlの蒸留水で洗浄し、菌
体を紙と共に105℃で18時間乾燥し、全乾燥重
量より紙及び添加珪藻土重量を差引いた値で示
した。第3表にその結果を示した。
The present invention relates to a method for culturing filamentous fungi. Conventionally, an example of culturing filamentous fungi by adding powder belonging to diatomaceous earth to a liquid medium for the purpose of producing useful substances is in penicillin G fermentation using filamentous fungi belonging to Penicillium chrysogenum. The only known example is that celite was added at a high concentration of 10% for the purpose of immobilization (DICWang et al., 1986 Japanese Society of Fermentation Engineering Abstracts, p. 112), and a low concentration of diatomaceous earth was added to a liquid medium. There have been no reports of cases in which filamentous fungi have been cultured with the addition of these substances. Generally, when filamentous fungi are cultured aerobically in a liquid medium, the hyphae grow into pellet-like (spherical) or pulp-like lumps, and sometimes these lumps grow so large that the production of the desired useful substance is significantly reduced. One of the drawbacks in the production of useful substances using filamentous fungi is the decrease in the production of useful substances. The present inventors aim to produce useful substances such as anti-inflammatory agents, organic acids, antibiotics, enzymes such as protease, glucoamylase, and glucose oxidase, L-amino acids, pigments, and enzyme inhibitors, which belong to filamentous fungi. As a result of culturing each of the producing bacteria in a culture solution containing diatomaceous earth, the inventors discovered that the mycelial masses were made finer and at the same time, the production of the target useful substance was significantly promoted, leading to the completion of the present invention. Ivy. That is, the present invention uses 8% of powder belonging to diatomaceous earth.
The present invention relates to a method for culturing filamentous fungi, which is characterized by culturing filamentous fungi aerobically in a liquid medium containing no more than . The diatomaceous earth used in the present invention has long been used as a supernatant, and there are various trade names depending on the manufacturer and particle size. for example
Johns-Manville products include various Celites "Celite 501-577,""Hyflo Super Cell," and "Filter Cell," while Showa Kagaku Kogyo Co., Ltd. products include various "Radiolite,""RapidFlow," and various "Torite." There is Hakusan Kogyo Co., Ltd.
There are various products such as ``Zemlite'' and ``Zemlite Super,'' Grefco products include various ``Dicalite,'' and Eagle-
Picher's products include various ``Celatom'' products.
There is. The diatomaceous earth used may be in its commonly available form (powder) and may be dry heat sterilized at 180-200°C separately from the medium before being added to the medium, or steam sterilized under normal conditions, or Steam sterilization may be performed together with the culture medium. By adding diatomaceous earth to the medium, spores and hyphae adhere to the diatomaceous earth particles, germinate using these as nuclei, and the hyphae are observed to grow.Furthermore, they do not adhere to the diatomaceous earth and do not form clumps. It can also be observed that they are growing without any problems. Thus, by adding diatomaceous earth, the mycelia grow without forming large clumps, the stirring efficiency of the medium is improved, and the growth rate and production of the desired useful substance are promoted. The useful substances produced in the present invention are useful substances produced by filamentous fungi, such as mycophenolic acid, anticancer agents such as cyclosporin, gluconic acid, citric acid, malic acid, pyruvic acid, itaconic acid, and araboascorbic acid. , organic acids such as kojic acid and aloisocitric acid, antibiotics such as penicillin and cephalosporin C, enzymes such as protease, glucoamylase, and glucose oxidase, L
-Amino acids, pigments and compactin, enzyme inhibitors. The filamentous fungus used in the present invention is not particularly limited as long as it is a filamentous fungus, and includes, for example, Penicillium brevicompactum that produces mycophenolic acid and compactin, Penicillium and chrysogenum that produce penicillin C, and glucose oxidase-producing bacteria. Penicillium perprogenum, Cephalosporium polyalerum which is a cephalosporin C producing bacterium, Aspergillus oryzae which is an amylase producing bacterium, Rhizopus derema, and Aspergillus derma which is a protease producing bacterium.
Cytoi, Aspergillus phenisis, Aspergillus niger, which produces citric acid and gluconic acid, and Alpergillus, which produces itaconic acid.
We can mention Tereus et al. Specifically, Penicillium brevi compactum, a mycophenolic acid-producing bacterium,
compactum), AJ117096, (FERM P-5693,
FERM BP-55), Penicillium chrysogenum (P. chrysogenum), a penicillin-producing bacterium
ATCC10002, AJ7343, Penicillium perprogenum No. which is a glucose oxidase producing bacterium.
778 (P. purprogenum) AJ17045 FERM−P1846,
Cephalosporium polyallerum (Cephalosporium polyallerum) is a cephalosporin C-producing bacterium.
polyaleurum) ATCC20359 AJ6993, protease producing bacteria include Aspergillus phenicis (Aspergillus phenicis) ATCC14332 AJ17063,
Aspergillus niger (A. niger) ATCC9642 as a glucoamylase and citric acid producing bacterium
AJ7172 etc. are used. The liquid medium used in the present invention may be any liquid medium in which filamentous fungi can grow, except for the addition of diatomaceous earth. For example, a well-known medium for producing mycophenolic acid, WL
Muth et al, Antimicrob, Agents
The culture medium described in Chemtherap., 8 , 321-327 (1975) is used. As a medium for penicillin fermentation
Synthetic medium of Lohnson et al. (Yusuke Sumiki “Antibiotics”)
above, p. 177, 1961) is used. As a medium for cephalosporin C fermentation, for example, AL
DEMAIN, JFNEWKIRK, and D.
HENDLIN, J. A modified medium (Table 4) of the medium described in Bacteriol. 85 , 339 (1963) is used. As the culture medium for producing glucose oxidase, for example, the culture medium described in Japanese Patent Publication No. 109/1982 is used (Table 6). As the culture medium for protease, glucoamylase and citric acid production, the media listed in Tables 5 and 6 are used. The amount of diatomaceous earth added does not exceed 8%,
Preferably it is 0.2 to 2%. The culture temperature may be any temperature as long as the filamentous fungus that produces the useful substance can grow, but it is preferable to use the optimal culture temperature that produces the useful substance. Culture is carried out with rotation or aeration under conditions suitable for the production of each useful substance. The rotation speed is 200-250 rpm. Diatomaceous earth can be added either singly or in combination. Various useful substances produced by the method of the present invention can be quantified and collected by each known method. Mycophenolic acid and citric acid in the culture solution were analyzed and quantified using high-performance liquid chromatography, aspartic acid was determined using the bioassay method, penicillin G was determined using the national assay method using Staphyloccus aureus, and cephalosporin C was determined using Comamonas.
ferrigena growth inhibition circle method was used. Glucoamylase activity was measured using the saccharification measurement method (Jikken Kagaku Koza, Vol. 24, p. 272, 1961), and protease activity was measured using the Casein-Folin color A method (Hagiwara, Enzyme Research Methods, Vol. 2, p. 237, 1956). The activity of glucose oxidase was measured by a pressure detection method using a Warburg manometer.As explained above, the present invention relates to a method for accumulating and collecting useful substances produced by filamentous fungi by adding diatomaceous earth to a culture medium. The method of the present invention significantly increases the production amount of useful substances by adding diatomaceous earth, and is industrially suitable in that diatomaceous earth can be easily recovered from the culture solution by incineration or other methods after harvesting the product. Its practical value is extremely large.Example 1 Penicillium brevicompactum AJ117096
(FERM P-5693, FERM BP-55) were inoculated onto the natural slant medium shown in Table 1, and after culturing at 27°C for 10 days, the spores were collected and added to 0.1M phosphate buffer (PH
6.8) and inoculated a certain volume of it into the medium shown in Table 2 (50 ml of medium in a 300 ml Erlenmeyer flask) (approximately 10 6 spores/ml), and incubated at 27°C for 12 days.
Rotary culture was performed at 226 rpm. When diatomaceous earth shown in Table 3 was added, it was sterilized by heating at 180° C. and then added to the medium at a concentration of 1%. After culturing,
Adjust the culture solution to PH10-10.5 with sodium hydroxide solution.
After adjusting and rotating at 150 rpm for 20 minutes, the Toyo paper
Pass through No. 2 to obtain a clear liquid. Mycophenolic acid in this liquid was determined by high performance liquid chromatography, and L-aspartic acid was determined by bioassay method. Bacterial growth was determined by washing the entire culture medium (50 ml) of bacterial cells with approximately 10 ml of distilled water, drying the bacterial cells together with paper at 105℃ for 18 hours, and subtracting the weight of paper and diatomaceous earth from the total dry weight. Indicated. Table 3 shows the results.
【表】【table】
【表】【table】
【表】
セライト535、セライト545及びフイルターセル
を添加した場合、いずれもミコフエノール酸及び
L−アスパラギン酸の蓄積は著しく増加した。一
方菌体の生育の程度は無添加の場合とは有意差は
なかつたが、ペレツトの大きさはこれらの添加に
よつて微細化された。
実施例 2
実施例1で示した方法に従つてペニシリウムブ
レビコンパクタムAJ117096(FERM P−5693、
FERM BP−55)を種々の濃度のセライト545を
含む第2表に示す培地で27℃12日間226rpmで回
転培養を行つた結果を第4表に示した。セライト
545を0.4〜8%添加によつてミコフエノール酸蓄
積は著しく促進された。[Table] When Celite 535, Celite 545, and Filter Cell were added, the accumulation of mycophenolic acid and L-aspartic acid significantly increased in all cases. On the other hand, although there was no significant difference in the degree of bacterial growth compared to the case without the addition, the size of the pellets became finer due to these additions. Example 2 Penicillium brevi compactum AJ117096 (FERM P-5693,
Table 4 shows the results of rotary culture of FERM BP-55) at 27°C for 12 days at 226 rpm in the medium shown in Table 2 containing various concentrations of Celite 545. Celite
Mycophenolic acid accumulation was significantly promoted by addition of 0.4 to 8% of 545.
【表】
実施例 3
実施例1で示した方法に従つて、第1表の培地
に生育したペニシリンGの生産菌のペニシリウ
ム・クリンゲナムATCC10002、AJ7343、セフア
ロスポリンC生産菌であるセフアロスポリウム・
ポリアレウラムATCC20359、AJ6993、プロテア
ーゼ生産菌であるアスペルギルス・フエニシス
ATCC14332、AJ17063、グルコアミラーゼ及び
クエン酸生産菌であるアスペルギルス・ニガー
ATCC9642、AJ7172、及びグルコースオキシダ
ーゼ生産菌であるペニシリウム・パープロゲナム
FERM−P1846、AJ17045菌糸及び胞子の懸濁液
を、第5、6、7表に示したそれぞれの生産培地
(300ml三角フラスコに50ml培地張込み)に接種
し、27℃で回転培養(226rpm)を行つた。培養
時間はペニシリンG、セフアロスポリンC、グル
コアミラーゼ生産の場合は5日間、プロテアーゼ
生産の場合は4日間、グルコースオキシダーゼ生
産の場合は6日間、クエン酸生産の場合は10日間
培養した。培養液中の各生産物の蓄積量は上記
した方法によつて測定した。これらの生産菌を珪
藻土存在下及び非存在下でのそれぞれの蓄積量を
測定した結果を第8表に示した。[Table] Example 3 According to the method shown in Example 1, penicillin G producing bacteria Penicillium clingenum ATCC10002 and AJ7343 were grown in the medium shown in Table 1, and cephalosporin C producing bacteria Cephalosporium
Polyaleurum ATCC20359, AJ6993, Aspergillus feinisis, a protease producing bacterium
ATCC14332, AJ17063, glucoamylase and citric acid producing bacterium Aspergillus niger
ATCC9642, AJ7172, and Penicillium perprogenum, a glucose oxidase-producing bacterium
Suspensions of FERM-P1846 and AJ17045 mycelia and spores were inoculated into the respective production media shown in Tables 5, 6, and 7 (50 ml medium filled in a 300 ml Erlenmeyer flask), and cultured by rotation at 27°C (226 rpm). I went there. The culture time was 5 days for penicillin G, cephalosporin C, and glucoamylase production, 4 days for protease production, 6 days for glucose oxidase production, and 10 days for citric acid production. The amount of each product accumulated in the culture solution was measured by the method described above. Table 8 shows the results of measuring the amounts of these producing bacteria in the presence and absence of diatomaceous earth.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
使用した珪藻土のいずれの場合も
セライト545で、1%になる様にそれぞれの生
産培地に添加した。いずれの場合もセライト添加
によつて蓄積増加がみられた。一方菌糸のペレツ
トは全般的にセライト添加によつて微細化され
た。[Table] In all cases of diatomaceous earth used, Celite 545 was added to each production medium at a concentration of 1%. In both cases, an increase in accumulation was observed with the addition of celite. On the other hand, the mycelial pellets were generally refined by the addition of Celite.
Claims (1)
で含有する液体培地中で糸状菌を好気的に培養す
ることを特徴とする糸状菌の培養法。1. A method for culturing filamentous fungi, which comprises culturing filamentous fungi aerobically in a liquid medium containing not more than 8% of powder belonging to diatomaceous earth.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23559083A JPS60126076A (en) | 1983-12-14 | 1983-12-14 | Culture of mold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23559083A JPS60126076A (en) | 1983-12-14 | 1983-12-14 | Culture of mold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60126076A JPS60126076A (en) | 1985-07-05 |
| JPH0322149B2 true JPH0322149B2 (en) | 1991-03-26 |
Family
ID=16988249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP23559083A Granted JPS60126076A (en) | 1983-12-14 | 1983-12-14 | Culture of mold |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60126076A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5106791B2 (en) * | 2006-06-07 | 2012-12-26 | 小野田ケミコ株式会社 | Revegetation base using crushed wood chips and replanting base construction method |
-
1983
- 1983-12-14 JP JP23559083A patent/JPS60126076A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60126076A (en) | 1985-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Batchelor et al. | 6-Aminopenicillanic acid VI. Formation of 6-aminopenicillanic acid from penicillin by enzymic hydrolysis | |
| US3634195A (en) | Production of lipase | |
| US4248966A (en) | Synthesis of isopenicillin derivatives in the absence of living cells | |
| US3622463A (en) | Production of extracellular glucose isomerase by streptomyces | |
| Erickson et al. | Penicillin acylase activity of Penicillium chrysogenum | |
| US3892629A (en) | Process for growing a fungus | |
| CN1935977B (en) | L-lactone hydrolase-producing bacteria and method for preparing chiral hydroxyacids | |
| NL8100476A (en) | PROCESS FOR THE PREPARATION OF AN ALFA-GALACTOXYDASE ENZYME AND METHOD FOR THE HYDROLYSIS OF RAFFINOSE USING THIS ENZYME | |
| US3398056A (en) | Process for producing lysostaphin by fermentation | |
| US3080297A (en) | Production of glutamic acid | |
| Katznelson | THE METABOLISM OF PHYTOPATHOGENIC BACTERIA I: Comparative Studies on the Metabolism of Representative Species | |
| US4248967A (en) | Enzymic complexes adapted to convert racemic hydantoins into optically active aminoacids, and their applications | |
| US5026641A (en) | Bacteria culture and fermentation using the same | |
| JPH0322149B2 (en) | ||
| Kim et al. | STUDIES ON MIKAMYCIN B LACTONASE I. DEGRADATION OF MIKAMYCIN B BY STREPTOMYCES MITAKAENSIS | |
| JPH07112428B2 (en) | Filamentous fungus culture method | |
| D'Amato et al. | A chemically defined medium for cephalosporin C production by Paecilomyces persicinus | |
| US4269942A (en) | Process for preparing acyl-CoA synthetase LCF-18 | |
| JPH0363350B2 (en) | ||
| JPS60164478A (en) | Method for cultivating mold | |
| EP0952227B1 (en) | A bio-resolution process | |
| Tauro et al. | L-Lysine production by Uestilaginales fungi | |
| JPS6225358B2 (en) | ||
| JPS62115274A (en) | Cultivation of microorganism | |
| JPS5857156B2 (en) | Production method of coenzyme Q↓1↓0 by fermentation method |